about
Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysisRelapsing polychondritisInternational and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry.Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.Buerger's disease and antiphospholipid syndromeDecreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitisUrogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature.Whipple disease revealed by lung involvement: a case report and literature review.Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study.Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study.Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides.[Whipple's disease].Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonistsEffects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imagingGranulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience.Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up.Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature.Characteristics and management of IgA vasculitis (Henoch-Schönlein purpura) in adults: Data from the 260 patients included in the IGAVAS survey.Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective studyAntineutrophil cytoplasmic antibody-associated vasculitides.Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.How to treat refractory arthritis in lupus?Abatacept therapy and safety management.Therapeutic immunomodulation in systemic vasculitis: taking stock.L12. Rheumatoid arthritis vasculitis.Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.A severe Whipple disease with an immune reconstitution inflammatory syndrome: an additional case of thalidomide efficiency.Ocular inflammatory diseases associated with rheumatoid arthritis.Mucormycosis in systemic autoimmune diseases.Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis with Polyangiitis, Microscopic Polyangiitis or Polyarteritis Nodosa without Poor Prognosis Factors A Randomized-Controlled Trial.ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review.
P50
Q28069646-5365C4C4-823E-4E9D-B3B5-B1AC425E49A5Q28307853-22ECFEC9-528A-4B04-ACCA-5A2AEB9BDDC8Q30234696-64622F9E-1BEF-4BA7-B543-5FF0A2DE0CA9Q30916093-CF44F69D-9FDF-4C47-BCB9-18D2AD81484FQ30948155-4603EAFA-6609-4B3E-9965-C7F687523DB9Q30991084-7F414DC4-8E87-47A4-98F9-475A08513786Q33501443-AF0BE57C-D86F-491F-B318-57F0202B73F4Q33565857-4B64FF7C-F9C7-491F-A564-210FBB924526Q33873640-8E684232-98A6-4951-8BF6-44FFFE49B7F9Q34258754-EA9B9558-C10B-42BB-9ACC-093CA852231EQ34279181-EF26FB7B-C37F-4E03-ACC8-FB164CF7C64CQ34332192-50359AF0-D4F7-4BB6-99A3-C2A1E2B52DC0Q34434927-0B0AE378-76F2-4A1D-91A3-96D5C4C82677Q34660075-1E102438-3A24-4F0E-B191-9A5CFB1F01D6Q34663199-889685F0-4548-445D-818A-80CFA8877638Q34743817-A844CC51-D12A-472D-AD70-975A4FA937A7Q34774282-DF77D75D-0E9A-4985-8BB9-869E45F44DE1Q34812345-F548D177-D0AF-4181-B63D-20A66D66C650Q35605635-995C6170-E0C8-4F7B-B749-C9364169A6A3Q35636702-0738DD38-557B-411E-B154-7CCFCA734684Q35639650-720ACC44-5DA3-408F-817B-9677FBC09F75Q36009033-59BCADC2-FBE2-4BFD-97D5-22EAC7AF0D1BQ36040078-FE4C38AA-1154-4A2B-9AF5-0CA39A5C8803Q36070691-771DF125-758D-4EC6-8107-1CE4BCD1D83DQ36152127-B8E3DE4D-C2B7-4496-BB36-AC9EFA288515Q36399314-272072E4-F238-4537-9DD6-CA9978EA3707Q36454542-60792E4C-10AB-425E-AEA1-EBC1C3045F95Q36508873-F586CB28-CB85-4998-B69A-A3555F3E9833Q36851498-BB6B86BE-6364-4163-8BBD-55DBE8B0F100Q37360522-DEF6E4BB-EB10-493F-A459-D5C2A1B1D122Q37985085-753C5B03-E71B-48A8-8AFD-4E4708DC22BAQ38006176-319476EA-2E6B-477B-8624-831F48C651D8Q38067212-649D4A0F-ADC5-4860-B96D-A69039CD56E2Q38088513-2DC7AA14-79A9-431B-A15E-017B41F94E96Q38157393-CB65ECAA-DD91-4849-93DE-39F5C983CC11Q38167411-E5DAA73D-637C-4E56-B3F5-5DF72D5DBFAAQ38169978-B62C12D6-D4B0-4CA8-AD35-AAE0957D6120Q38193975-E10C9679-D198-413A-91A3-4C02F050FA2BQ38374545-C513BF42-CFA5-4205-A4BE-6827F7FEA6CBQ38444702-B40B3993-96B3-4AC0-9263-3E7B25B3D02E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xavier Puéchal
@ast
Xavier Puéchal
@en
Xavier Puéchal
@es
Xavier Puéchal
@sl
type
label
Xavier Puéchal
@ast
Xavier Puéchal
@en
Xavier Puéchal
@es
Xavier Puéchal
@sl
prefLabel
Xavier Puéchal
@ast
Xavier Puéchal
@en
Xavier Puéchal
@es
Xavier Puéchal
@sl
P1053
P-1555-2017
P106
P1153
7003370704
P21
P31
P3829
P496
0000-0003-3573-9203